JP2010083898A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010083898A5 JP2010083898A5 JP2009298925A JP2009298925A JP2010083898A5 JP 2010083898 A5 JP2010083898 A5 JP 2010083898A5 JP 2009298925 A JP2009298925 A JP 2009298925A JP 2009298925 A JP2009298925 A JP 2009298925A JP 2010083898 A5 JP2010083898 A5 JP 2010083898A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12868699P | 1999-04-09 | 1999-04-09 | |
US60/128,686 | 1999-04-09 | ||
US18620100P | 2000-03-01 | 2000-03-01 | |
US60/186,201 | 2000-03-01 | ||
US19011100P | 2000-03-20 | 2000-03-20 | |
US60/190,111 | 2000-03-20 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000611685A Division JP2002542169A (ja) | 1999-04-09 | 2000-04-10 | Clostridiumdifficileに対する、組換え毒素A/毒素Bワクチン |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010083898A JP2010083898A (ja) | 2010-04-15 |
JP2010083898A5 true JP2010083898A5 (ja) | 2010-10-07 |
JP5566684B2 JP5566684B2 (ja) | 2014-08-06 |
Family
ID=27383767
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000611685A Pending JP2002542169A (ja) | 1999-04-09 | 2000-04-10 | Clostridiumdifficileに対する、組換え毒素A/毒素Bワクチン |
JP2009298925A Expired - Fee Related JP5566684B2 (ja) | 1999-04-09 | 2009-12-28 | Clostridiumdifficileに対する、組換え毒素A/毒素Bワクチン |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000611685A Pending JP2002542169A (ja) | 1999-04-09 | 2000-04-10 | Clostridiumdifficileに対する、組換え毒素A/毒素Bワクチン |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1169456B1 (ja) |
JP (2) | JP2002542169A (ja) |
AU (1) | AU781175B2 (ja) |
CA (1) | CA2365915C (ja) |
WO (1) | WO2000061762A1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205206D0 (en) * | 2002-03-06 | 2002-04-17 | Oxoid Ltd | Synthetic peptides |
US6912151B2 (en) | 2002-06-28 | 2005-06-28 | Synopsys, Inc. | Negative differential resistance (NDR) based memory device with reduced body effects |
EP2373332A1 (en) * | 2008-12-03 | 2011-10-12 | Boehringer Ingelheim Vetmedica GmbH | Process for production of vaccines |
EP2753352B2 (en) * | 2010-09-03 | 2022-08-10 | Valneva Austria GmbH | Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof |
GB201016742D0 (en) | 2010-10-05 | 2010-11-17 | Health Prot Agency | Clostridium difficile antigens |
BR112013027229B1 (pt) | 2011-04-22 | 2020-10-27 | Wyeth Llc | polipeptídeo imunogênico isolado e seu uso, composição imunogênica e seu uso, célula recombinante ou progênie da mesma, e método de produção de uma toxina de clostridium difficile mutante |
AU2016203241B2 (en) * | 2011-05-27 | 2018-05-10 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
SI2714911T1 (sl) | 2011-05-27 | 2017-03-31 | Glaxosmithkline Biologicals S.A. | Imunogeni sestavek |
ES2704069T3 (es) | 2011-12-08 | 2019-03-14 | Glaxosmithkline Biologicals Sa | Vacuna basada en toxinas de Clostridium difficile |
GB201206070D0 (en) | 2012-04-04 | 2012-05-16 | Health Prot Agency | Clostridium difficile antigens |
BR122016023101B1 (pt) | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
FI3513806T3 (fi) | 2012-12-05 | 2023-04-26 | Glaxosmithkline Biologicals Sa | Immunogeeninen koostumus |
US10287330B2 (en) | 2012-12-27 | 2019-05-14 | Glaxosmithkline Biologicals S.A. | Methods and compositions relating to CRM197 |
EP3160500B1 (en) | 2014-06-25 | 2019-08-21 | GlaxoSmithKline Biologicals S.A. | Clostridium difficile immunogenic composition |
WO2016131157A1 (en) | 2015-02-19 | 2016-08-25 | Immune Biosolutions Inc | Clostridium difficile toxins a and/or b antigen and epitope antibody, and pharmaceutical uses thereof |
MX2020013623A (es) | 2018-06-19 | 2021-03-25 | Glaxosmithkline Biologicals Sa | Composicion inmunogenica. |
JP2022513077A (ja) * | 2018-11-16 | 2022-02-07 | マトリバックス,インコーポレーテッド | クロストリジウム・ディフィシル多成分ワクチン |
CN112442472B (zh) * | 2020-11-30 | 2023-05-26 | 四川大学华西医院 | 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法 |
GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
WO2024160901A1 (en) | 2023-02-02 | 2024-08-08 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879218A (en) | 1982-09-13 | 1989-11-07 | Virginia Tech Intellectual Properties, Inc. | Antibody for C.difficile |
US4533630A (en) | 1982-09-13 | 1985-08-06 | Wilkins Tracy D | Toxins and antibodies of C. difficile |
US4530833A (en) | 1982-09-13 | 1985-07-23 | Wilkins Tracy D | Toxins and antibodies of C. difficile |
US4863852A (en) | 1985-07-03 | 1989-09-05 | Virginia Tech Intellectual Properties, Inc. | Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors |
GB8517071D0 (en) * | 1985-07-05 | 1985-08-14 | Hoffmann La Roche | Gram-positive expression control sequence |
US5736139A (en) | 1989-10-31 | 1998-04-07 | Ochidian Pharmaceuticals, Inc. | Treatment of Clostridium difficile induced disease |
US5098826A (en) | 1990-03-09 | 1992-03-24 | Virginia Tech Intellectual Properties, Inc. | Detection, isolation and purification of Clostridium difficile toxin A with toxin receptors |
US7018809B1 (en) * | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
AU709586B2 (en) * | 1994-10-24 | 1999-09-02 | Ophidian Pharmaceuticals, Inc. | Vaccine and antitoxin for treatment and prevention of C. difficile disease |
JPH11509200A (ja) * | 1995-07-07 | 1999-08-17 | オラバックス インク. | 粘膜アジュバントとしてのクロストリジウム・ディフィシール(Clostridium Difficile)トキシン |
US5919463A (en) | 1995-07-07 | 1999-07-06 | Oravax, Inc. | Clostridium difficle toxins as mucosal adjuvants |
JPH09323999A (ja) * | 1996-06-03 | 1997-12-16 | Unitika Ltd | 人工タンパク質ポリマー |
WO1998059053A1 (en) * | 1997-06-20 | 1998-12-30 | Queen Mary & Westfield College | Immonogenic fragments of toxin a of clostridium difficile |
-
2000
- 2000-04-10 AU AU49732/00A patent/AU781175B2/en not_active Ceased
- 2000-04-10 EP EP00931926A patent/EP1169456B1/en not_active Expired - Lifetime
- 2000-04-10 CA CA2365915A patent/CA2365915C/en not_active Expired - Fee Related
- 2000-04-10 JP JP2000611685A patent/JP2002542169A/ja active Pending
- 2000-04-10 WO PCT/US2000/009525 patent/WO2000061762A1/en active Search and Examination
- 2000-04-10 EP EP12155470A patent/EP2502998A3/en not_active Withdrawn
-
2009
- 2009-12-28 JP JP2009298925A patent/JP5566684B2/ja not_active Expired - Fee Related